These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8285884)

  • 41. Cytomegalovirus retinitis: new developments in prophylaxis and therapy.
    Jacobson MA
    AIDS Clin Rev; 1997-1998; ():249-69. PubMed ID: 9305451
    [No Abstract]   [Full Text] [Related]  

  • 42. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
    Jabs DA
    Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined ganciclovir and foscarnet in pediatric cytomegalovirus retinitis.
    Sastry SM; Epps CH; Walton RC; Rana SN; Sanders RJ
    J Natl Med Assoc; 1996 Oct; 88(10):661-2. PubMed ID: 8918073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group.
    Arch Intern Med; 1995 Jan; 155(1):65-74. PubMed ID: 7802522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment with intravitreous ganciclovir in cytomegalovirus retinitis associated with AIDS].
    Gutiérrez A; Martín I; Ferrer E; Torrón C; Aguirre JM
    Enferm Infecc Microbiol Clin; 1992 Dec; 10(10):629-30. PubMed ID: 1337981
    [No Abstract]   [Full Text] [Related]  

  • 46. [Intravitreal injection of ganciclovir in AIDS patients with cytomegalovirus retinitis].
    Fujino Y; Nagata Y; Miyoshi M; Ono A; Oka S; Iwamoto A; Kimura S; Mochizuki M
    Nippon Ganka Gakkai Zasshi; 1996 Aug; 100(8):634-40. PubMed ID: 8810241
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
    Kirsch LS; Arevalo JF; De Clercq E; Chavez de la Paz E; Munguia D; Garcia R; Freeman WR
    Am J Ophthalmol; 1995 Apr; 119(4):466-76. PubMed ID: 7709971
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intraocular device for cytomegalovirus infection.
    Ernest JT
    Lancet; 1995 Oct; 346(8981):983-4. PubMed ID: 7475587
    [No Abstract]   [Full Text] [Related]  

  • 49. Ganciclovir implant in the treatment of cytomegalovirus retinitis.
    Chang M; Dunn JP
    Expert Rev Med Devices; 2005 Jul; 2(4):421-7. PubMed ID: 16293081
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two-drug treatment effective against recurrent CMV retinitis.
    NIAID AIDS Agenda; 1996 Mar; ():8. PubMed ID: 11363802
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunohistochemical localization of ganciclovir in the human retina.
    Park SS; Girard B; Font RL; Hauw JJ; Young LH
    Curr Eye Res; 1998 Jun; 17(6):663-7. PubMed ID: 9663857
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group.
    Drew WL; Ives D; Lalezari JP; Crumpacker C; Follansbee SE; Spector SA; Benson CA; Friedberg DN; Hubbard L; Stempien MJ
    N Engl J Med; 1995 Sep; 333(10):615-20. PubMed ID: 7637721
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytomegalovirus retinitis in AIDS patients: a clinical review.
    Vendrell CP; Ramírez-Ronda CH
    Bol Asoc Med P R; 1994; 86(7-9):62-7. PubMed ID: 7945655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytomegalovirus optic neuritis: characteristics, therapy and survival.
    Mansor AM; Li HK
    Ophthalmologica; 1995; 209(5):260-6. PubMed ID: 8570149
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis.
    Arevalo JF; Gonzalez C; Capparelli EV; Kirsch LS; Garcia RF; Quiceno JI; Connor JD; Gambertoglio J; Bergeron-Lynn G; Freeman WR
    J Infect Dis; 1995 Oct; 172(4):951-6. PubMed ID: 7561215
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endophthalmitis as a complication of intravitreal treatment for cytomegalovirus retinitis.
    Collazos J; Díaz F; Mayo J; Martínez E; Fernández A
    AIDS; 1995 Aug; 9(8):980-1. PubMed ID: 7576342
    [No Abstract]   [Full Text] [Related]  

  • 57. Current management of cytomegalovirus retinitis in AIDS update on ganciclovir and foscarnet for CMV infections.
    Jacobson MA
    Adv Exp Med Biol; 1996; 394():85-92. PubMed ID: 8815712
    [No Abstract]   [Full Text] [Related]  

  • 58. A sensitive and specific polymerase chain reaction-based assay for the diagnosis of cytomegalovirus retinitis.
    McCann JD; Margolis TP; Wong MG; Kuppermann BD; Luckie AP; Schwartz DM; Irvine AR; Ai E
    Am J Ophthalmol; 1995 Aug; 120(2):219-26. PubMed ID: 7639306
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir.
    Anand R; Nightingale SD; Fish RH; Smith TJ; Ashton P
    Arch Ophthalmol; 1993 Feb; 111(2):223-7. PubMed ID: 8141855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Once-weekly intraocular injections of ganciclovir for maintenance therapy of cytomegalovirus retinitis: clinical and ocular outcome.
    Hodge WG; Lalonde RG; Sampalis J; Deschênes J
    J Infect Dis; 1996 Aug; 174(2):393-6. PubMed ID: 8699072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.